2022-RA-1486-ESGO Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England

Angela Whittle; Betina Blak; Amy Zalin-Miller; Orlaith Condon

doi:10.1136/ijgc-2022-ESGO.728

Article info

Ovarian cancer

2022-RA-1486-ESGO Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England

Free

Authors

Angela Whittle Medical affairs, Oncology Business Unit, AstraZeneca UK Ltd, London, UK PubMed articles Google scholar articles
Betina Blak Medical affairs, Oncology Business Unit, AstraZeneca UK Ltd, London, UK PubMed articles Google scholar articles
Amy Zalin-Miller Health Data Insight, Cambridge, UK National Disease Registration Service at NHS Digital, Cambridge, UK PubMed articles Google scholar articles
Orlaith Condon Medical affairs, Oncology Business Unit, AstraZeneca UK Ltd, London, UK PubMed articles Google scholar articles

Citation

Whittle A, Blak B, Zalin-Miller A, et al

2022-RA-1486-ESGO Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England

International Journal of Gynecologic Cancer 2022;32:A342-A343.

Publication history

First published October 20, 2022.

Online issue publication

October 20, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password